title: Searching novel diagnostic markers and targets for therapy of CKD.
abstract: Over the last decade, identification and characterization of novel markers of progression and targets for therapy of chronic kidney disease (CKD) have been challenging for the research community. Several promising candidates have emerged, mainly from experimental models of CKD that are yet to be investigated in clinical studies. The authors identified two candidate genes:periostin, an extracellular matrix protein involved in bone and dental development, and the discoidin domain receptor 1(DDR1), a collagen-binding membrane receptor with tyrosine kinase activity. Both genes are inactive in adulthood under normal conditions but have been shown to be highly inducible following injury to glomerular or tubular epithelial cells. The objective of this review is to summarize recent evidence supporting the role of periostin and DDR1 as potential novel biomarkers and therapeutic targets in CKD.
authors: Inserm UMR-S 1155, UPMC (Université Pierre-et-Marie-Curie)-University of Paris VI, Sorbonne Universités , Paris, France.
authors: Panos
authors: P
authors: Kavvadas
authors: Inserm UMR-S 1155, UPMC (Université Pierre-et-Marie-Curie)-University of Paris VI, Sorbonne Universités , Paris, France.
authors: Jean-Claude
authors: JC
authors: Dussaule
authors: Inserm UMR-S 1155, UPMC (Université Pierre-et-Marie-Curie)-University of Paris VI, Sorbonne Universités , Paris, France.
authors: Christos
authors: C
authors: Chatziantoniou
keywords: DDR1; periostin; renal inflammation and fibrosis